高親和性神経成長因子受容体の世界市場（～2026年）

• 英文タイトル：Global High Affinity Nerve Growth Factor Receptor Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY01163 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は高親和性神経成長因子受容体のグローバル市場について調査・分析したレポートです。種類別（ASP-7962、AZD-7451、BNN-27、セネゲルミン、CRB-0089、その他）市場規模、用途別（胆管がん、乳頭状甲状腺がん、腰痛、肺がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別高親和性神経成長因子受容体の競争状況、市場シェア ・世界の高親和性神経成長因子受容体市場：種類別市場規模 2015年-2020年（ASP-7962、AZD-7451、BNN-27、セネゲルミン、CRB-0089、その他） ・世界の高親和性神経成長因子受容体市場：種類別市場規模予測 2021年-2026年（ASP-7962、AZD-7451、BNN-27、セネゲルミン、CRB-0089、その他） ・世界の高親和性神経成長因子受容体市場：用途別市場規模 2015年-2020年（胆管がん、乳頭状甲状腺がん、腰痛、肺がん、その他） ・世界の高親和性神経成長因子受容体市場：用途別市場規模予測 2021年-2026年（胆管がん、乳頭状甲状腺がん、腰痛、肺がん、その他） ・北米の高親和性神経成長因子受容体市場分析：米国、カナダ ・ヨーロッパの高親和性神経成長因子受容体市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの高親和性神経成長因子受容体市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の高親和性神経成長因子受容体市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの高親和性神経成長因子受容体市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Array BioPharma Inc、Astellas Pharma Inc、AstraZeneca Plc、Daiichi Sankyo Co Ltd、Dompe Farmaceutici SpA、Genzyme Corp、Handok Inc、Ignyta Inc、Loxo Oncology Inc、Merck & Co Inc、Nerviano Medical Sciences Srl、Plexxikon Inc、Proximagen Ltd、Rottapharm Biotech Srl、Sienna Biopharmaceuticals Inc、Tiziana Life Sciences Plc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global High Affinity Nerve Growth Factor Receptor Market
The global High Affinity Nerve Growth Factor Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global High Affinity Nerve Growth Factor Receptor Scope and Market Size
High Affinity Nerve Growth Factor Receptor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global High Affinity Nerve Growth Factor Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the High Affinity Nerve Growth Factor Receptor market is segmented into
ASP-7962
AZD-7451
BNN-27
Cenegermin
CRB-0089
Others

Segment by Application, the High Affinity Nerve Growth Factor Receptor market is segmented into
Bile Duct Cancer
Papillary Thyroid Cancer
Low Back Pain
Lung Cancer
Others

Regional and Country-level Analysis
The High Affinity Nerve Growth Factor Receptor market is analysed and market size information is provided by regions (countries).
The key regions covered in the High Affinity Nerve Growth Factor Receptor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and High Affinity Nerve Growth Factor Receptor Market Share Analysis
High Affinity Nerve Growth Factor Receptor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in High Affinity Nerve Growth Factor Receptor business, the date to enter into the High Affinity Nerve Growth Factor Receptor market, High Affinity Nerve Growth Factor Receptor product introduction, recent developments, etc.

The major vendors covered:
Array BioPharma Inc
Astellas Pharma Inc
AstraZeneca Plc
Daiichi Sankyo Co Ltd
Dompe Farmaceutici SpA
Genzyme Corp
Handok Inc
Ignyta Inc
Loxo Oncology Inc
Merck & Co Inc
Nerviano Medical Sciences Srl
Plexxikon Inc
Proximagen Ltd
Rottapharm Biotech Srl
Sienna Biopharmaceuticals Inc
Tiziana Life Sciences Plc

レポート目次

---

1 Study Coverage
1.1 High Affinity Nerve Growth Factor Receptor Product Introduction
1.2 Market Segments
1.3 Key High Affinity Nerve Growth Factor Receptor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate by Type
1.4.2 ASP-7962
1.4.3 AZD-7451
1.4.4 BNN-27
1.4.5 Cenegermin
1.4.6 CRB-0089
1.4.7 Others
1.5 Market by Application
1.5.1 Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate by Application
1.5.2 Bile Duct Cancer
1.5.3 Papillary Thyroid Cancer
1.5.4 Low Back Pain
1.5.5 Lung Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global High Affinity Nerve Growth Factor Receptor Market Size, Estimates and Forecasts
2.1.1 Global High Affinity Nerve Growth Factor Receptor Revenue 2015-2026
2.1.2 Global High Affinity Nerve Growth Factor Receptor Sales 2015-2026
2.2 Global High Affinity Nerve Growth Factor Receptor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global High Affinity Nerve Growth Factor Receptor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global High Affinity Nerve Growth Factor Receptor Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global High Affinity Nerve Growth Factor Receptor Competitor Landscape by Players
3.1 High Affinity Nerve Growth Factor Receptor Sales by Manufacturers
3.1.1 High Affinity Nerve Growth Factor Receptor Sales by Manufacturers (2015-2020)
3.1.2 High Affinity Nerve Growth Factor Receptor Sales Market Share by Manufacturers (2015-2020)
3.2 High Affinity Nerve Growth Factor Receptor Revenue by Manufacturers
3.2.1 High Affinity Nerve Growth Factor Receptor Revenue by Manufacturers (2015-2020)
3.2.2 High Affinity Nerve Growth Factor Receptor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global High Affinity Nerve Growth Factor Receptor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by High Affinity Nerve Growth Factor Receptor Revenue in 2019
3.2.5 Global High Affinity Nerve Growth Factor Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 High Affinity Nerve Growth Factor Receptor Price by Manufacturers
3.4 High Affinity Nerve Growth Factor Receptor Manufacturing Base Distribution, Product Types
3.4.1 High Affinity Nerve Growth Factor Receptor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers High Affinity Nerve Growth Factor Receptor Product Type
3.4.3 Date of International Manufacturers Enter into High Affinity Nerve Growth Factor Receptor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global High Affinity Nerve Growth Factor Receptor Market Size by Type (2015-2020)
4.1.1 Global High Affinity Nerve Growth Factor Receptor Sales by Type (2015-2020)
4.1.2 Global High Affinity Nerve Growth Factor Receptor Revenue by Type (2015-2020)
4.1.3 High Affinity Nerve Growth Factor Receptor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global High Affinity Nerve Growth Factor Receptor Market Size Forecast by Type (2021-2026)
4.2.1 Global High Affinity Nerve Growth Factor Receptor Sales Forecast by Type (2021-2026)
4.2.2 Global High Affinity Nerve Growth Factor Receptor Revenue Forecast by Type (2021-2026)
4.2.3 High Affinity Nerve Growth Factor Receptor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global High Affinity Nerve Growth Factor Receptor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global High Affinity Nerve Growth Factor Receptor Market Size by Application (2015-2020)
5.1.1 Global High Affinity Nerve Growth Factor Receptor Sales by Application (2015-2020)
5.1.2 Global High Affinity Nerve Growth Factor Receptor Revenue by Application (2015-2020)
5.1.3 High Affinity Nerve Growth Factor Receptor Price by Application (2015-2020)
5.2 High Affinity Nerve Growth Factor Receptor Market Size Forecast by Application (2021-2026)
5.2.1 Global High Affinity Nerve Growth Factor Receptor Sales Forecast by Application (2021-2026)
5.2.2 Global High Affinity Nerve Growth Factor Receptor Revenue Forecast by Application (2021-2026)
5.2.3 Global High Affinity Nerve Growth Factor Receptor Price Forecast by Application (2021-2026)

6 North America
6.1 North America High Affinity Nerve Growth Factor Receptor by Country
6.1.1 North America High Affinity Nerve Growth Factor Receptor Sales by Country
6.1.2 North America High Affinity Nerve Growth Factor Receptor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America High Affinity Nerve Growth Factor Receptor Market Facts & Figures by Type
6.3 North America High Affinity Nerve Growth Factor Receptor Market Facts & Figures by Application

7 Europe
7.1 Europe High Affinity Nerve Growth Factor Receptor by Country
7.1.1 Europe High Affinity Nerve Growth Factor Receptor Sales by Country
7.1.2 Europe High Affinity Nerve Growth Factor Receptor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe High Affinity Nerve Growth Factor Receptor Market Facts & Figures by Type
7.3 Europe High Affinity Nerve Growth Factor Receptor Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific High Affinity Nerve Growth Factor Receptor by Region
8.1.1 Asia Pacific High Affinity Nerve Growth Factor Receptor Sales by Region
8.1.2 Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific High Affinity Nerve Growth Factor Receptor Market Facts & Figures by Type
8.3 Asia Pacific High Affinity Nerve Growth Factor Receptor Market Facts & Figures by Application

9 Latin America
9.1 Latin America High Affinity Nerve Growth Factor Receptor by Country
9.1.1 Latin America High Affinity Nerve Growth Factor Receptor Sales by Country
9.1.2 Latin America High Affinity Nerve Growth Factor Receptor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America High Affinity Nerve Growth Factor Receptor Market Facts & Figures by Type
9.3 Central & South America High Affinity Nerve Growth Factor Receptor Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa High Affinity Nerve Growth Factor Receptor by Country
10.1.1 Middle East and Africa High Affinity Nerve Growth Factor Receptor Sales by Country
10.1.2 Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa High Affinity Nerve Growth Factor Receptor Market Facts & Figures by Type
10.3 Middle East and Africa High Affinity Nerve Growth Factor Receptor Market Facts & Figures by Application

11 Company Profiles
11.1 Array BioPharma Inc
11.1.1 Array BioPharma Inc Corporation Information
11.1.2 Array BioPharma Inc Description and Business Overview
11.1.3 Array BioPharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Products Offered
11.1.5 Array BioPharma Inc Related Developments
11.2 Astellas Pharma Inc
11.2.1 Astellas Pharma Inc Corporation Information
11.2.2 Astellas Pharma Inc Description and Business Overview
11.2.3 Astellas Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Products Offered
11.2.5 Astellas Pharma Inc Related Developments
11.3 AstraZeneca Plc
11.3.1 AstraZeneca Plc Corporation Information
11.3.2 AstraZeneca Plc Description and Business Overview
11.3.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Products Offered
11.3.5 AstraZeneca Plc Related Developments
11.4 Daiichi Sankyo Co Ltd
11.4.1 Daiichi Sankyo Co Ltd Corporation Information
11.4.2 Daiichi Sankyo Co Ltd Description and Business Overview
11.4.3 Daiichi Sankyo Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Products Offered
11.4.5 Daiichi Sankyo Co Ltd Related Developments
11.5 Dompe Farmaceutici SpA
11.5.1 Dompe Farmaceutici SpA Corporation Information
11.5.2 Dompe Farmaceutici SpA Description and Business Overview
11.5.3 Dompe Farmaceutici SpA Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Products Offered
11.5.5 Dompe Farmaceutici SpA Related Developments
11.6 Genzyme Corp
11.6.1 Genzyme Corp Corporation Information
11.6.2 Genzyme Corp Description and Business Overview
11.6.3 Genzyme Corp Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Genzyme Corp High Affinity Nerve Growth Factor Receptor Products Offered
11.6.5 Genzyme Corp Related Developments
11.7 Handok Inc
11.7.1 Handok Inc Corporation Information
11.7.2 Handok Inc Description and Business Overview
11.7.3 Handok Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Handok Inc High Affinity Nerve Growth Factor Receptor Products Offered
11.7.5 Handok Inc Related Developments
11.8 Ignyta Inc
11.8.1 Ignyta Inc Corporation Information
11.8.2 Ignyta Inc Description and Business Overview
11.8.3 Ignyta Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Ignyta Inc High Affinity Nerve Growth Factor Receptor Products Offered
11.8.5 Ignyta Inc Related Developments
11.9 Loxo Oncology Inc
11.9.1 Loxo Oncology Inc Corporation Information
11.9.2 Loxo Oncology Inc Description and Business Overview
11.9.3 Loxo Oncology Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Products Offered
11.9.5 Loxo Oncology Inc Related Developments
11.10 Merck & Co Inc
11.10.1 Merck & Co Inc Corporation Information
11.10.2 Merck & Co Inc Description and Business Overview
11.10.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Products Offered
11.10.5 Merck & Co Inc Related Developments
11.1 Array BioPharma Inc
11.1.1 Array BioPharma Inc Corporation Information
11.1.2 Array BioPharma Inc Description and Business Overview
11.1.3 Array BioPharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Products Offered
11.1.5 Array BioPharma Inc Related Developments
11.12 Plexxikon Inc
11.12.1 Plexxikon Inc Corporation Information
11.12.2 Plexxikon Inc Description and Business Overview
11.12.3 Plexxikon Inc Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Plexxikon Inc Products Offered
11.12.5 Plexxikon Inc Related Developments
11.13 Proximagen Ltd
11.13.1 Proximagen Ltd Corporation Information
11.13.2 Proximagen Ltd Description and Business Overview
11.13.3 Proximagen Ltd Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Proximagen Ltd Products Offered
11.13.5 Proximagen Ltd Related Developments
11.14 Rottapharm Biotech Srl
11.14.1 Rottapharm Biotech Srl Corporation Information
11.14.2 Rottapharm Biotech Srl Description and Business Overview
11.14.3 Rottapharm Biotech Srl Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Rottapharm Biotech Srl Products Offered
11.14.5 Rottapharm Biotech Srl Related Developments
11.15 Sienna Biopharmaceuticals Inc
11.15.1 Sienna Biopharmaceuticals Inc Corporation Information
11.15.2 Sienna Biopharmaceuticals Inc Description and Business Overview
11.15.3 Sienna Biopharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Sienna Biopharmaceuticals Inc Products Offered
11.15.5 Sienna Biopharmaceuticals Inc Related Developments
11.16 Tiziana Life Sciences Plc
11.16.1 Tiziana Life Sciences Plc Corporation Information
11.16.2 Tiziana Life Sciences Plc Description and Business Overview
11.16.3 Tiziana Life Sciences Plc Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Tiziana Life Sciences Plc Products Offered
11.16.5 Tiziana Life Sciences Plc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 High Affinity Nerve Growth Factor Receptor Market Estimates and Projections by Region
12.1.1 Global High Affinity Nerve Growth Factor Receptor Sales Forecast by Regions 2021-2026
12.1.2 Global High Affinity Nerve Growth Factor Receptor Revenue Forecast by Regions 2021-2026
12.2 North America High Affinity Nerve Growth Factor Receptor Market Size Forecast (2021-2026)
12.2.1 North America: High Affinity Nerve Growth Factor Receptor Sales Forecast (2021-2026)
12.2.2 North America: High Affinity Nerve Growth Factor Receptor Revenue Forecast (2021-2026)
12.2.3 North America: High Affinity Nerve Growth Factor Receptor Market Size Forecast by Country (2021-2026)
12.3 Europe High Affinity Nerve Growth Factor Receptor Market Size Forecast (2021-2026)
12.3.1 Europe: High Affinity Nerve Growth Factor Receptor Sales Forecast (2021-2026)
12.3.2 Europe: High Affinity Nerve Growth Factor Receptor Revenue Forecast (2021-2026)
12.3.3 Europe: High Affinity Nerve Growth Factor Receptor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific High Affinity Nerve Growth Factor Receptor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: High Affinity Nerve Growth Factor Receptor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: High Affinity Nerve Growth Factor Receptor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: High Affinity Nerve Growth Factor Receptor Market Size Forecast by Region (2021-2026)
12.5 Latin America High Affinity Nerve Growth Factor Receptor Market Size Forecast (2021-2026)
12.5.1 Latin America: High Affinity Nerve Growth Factor Receptor Sales Forecast (2021-2026)
12.5.2 Latin America: High Affinity Nerve Growth Factor Receptor Revenue Forecast (2021-2026)
12.5.3 Latin America: High Affinity Nerve Growth Factor Receptor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa High Affinity Nerve Growth Factor Receptor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: High Affinity Nerve Growth Factor Receptor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: High Affinity Nerve Growth Factor Receptor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: High Affinity Nerve Growth Factor Receptor Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key High Affinity Nerve Growth Factor Receptor Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 High Affinity Nerve Growth Factor Receptor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. High Affinity Nerve Growth Factor Receptor Market Segments
Table 2. Ranking of Global Top High Affinity Nerve Growth Factor Receptor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ASP-7962
Table 5. Major Manufacturers of AZD-7451
Table 6. Major Manufacturers of BNN-27
Table 7. Major Manufacturers of Cenegermin
Table 8. Major Manufacturers of CRB-0089
Table 9. Major Manufacturers of Others
Table 10. Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global High Affinity Nerve Growth Factor Receptor Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global High Affinity Nerve Growth Factor Receptor Sales by Regions 2015-2020 (K Pcs)
Table 13. Global High Affinity Nerve Growth Factor Receptor Sales Market Share by Regions (2015-2020)
Table 14. Global High Affinity Nerve Growth Factor Receptor Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global High Affinity Nerve Growth Factor Receptor Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global High Affinity Nerve Growth Factor Receptor Sales Share by Manufacturers (2015-2020)
Table 17. Global High Affinity Nerve Growth Factor Receptor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global High Affinity Nerve Growth Factor Receptor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in High Affinity Nerve Growth Factor Receptor as of 2019)
Table 19. High Affinity Nerve Growth Factor Receptor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. High Affinity Nerve Growth Factor Receptor Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers High Affinity Nerve Growth Factor Receptor Price (2015-2020) (USD/Pcs)
Table 22. High Affinity Nerve Growth Factor Receptor Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers High Affinity Nerve Growth Factor Receptor Product Type
Table 24. Date of International Manufacturers Enter into High Affinity Nerve Growth Factor Receptor Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global High Affinity Nerve Growth Factor Receptor Sales by Type (2015-2020) (K Pcs)
Table 27. Global High Affinity Nerve Growth Factor Receptor Sales Share by Type (2015-2020)
Table 28. Global High Affinity Nerve Growth Factor Receptor Revenue by Type (2015-2020) (US$ Million)
Table 29. Global High Affinity Nerve Growth Factor Receptor Revenue Share by Type (2015-2020)
Table 30. High Affinity Nerve Growth Factor Receptor Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global High Affinity Nerve Growth Factor Receptor Sales by Application (2015-2020) (K Pcs)
Table 32. Global High Affinity Nerve Growth Factor Receptor Sales Share by Application (2015-2020)
Table 33. North America High Affinity Nerve Growth Factor Receptor Sales by Country (2015-2020) (K Pcs)
Table 34. North America High Affinity Nerve Growth Factor Receptor Sales Market Share by Country (2015-2020)
Table 35. North America High Affinity Nerve Growth Factor Receptor Revenue by Country (2015-2020) (US$ Million)
Table 36. North America High Affinity Nerve Growth Factor Receptor Revenue Market Share by Country (2015-2020)
Table 37. North America High Affinity Nerve Growth Factor Receptor Sales by Type (2015-2020) (K Pcs)
Table 38. North America High Affinity Nerve Growth Factor Receptor Sales Market Share by Type (2015-2020)
Table 39. North America High Affinity Nerve Growth Factor Receptor Sales by Application (2015-2020) (K Pcs)
Table 40. North America High Affinity Nerve Growth Factor Receptor Sales Market Share by Application (2015-2020)
Table 41. Europe High Affinity Nerve Growth Factor Receptor Sales by Country (2015-2020) (K Pcs)
Table 42. Europe High Affinity Nerve Growth Factor Receptor Sales Market Share by Country (2015-2020)
Table 43. Europe High Affinity Nerve Growth Factor Receptor Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe High Affinity Nerve Growth Factor Receptor Revenue Market Share by Country (2015-2020)
Table 45. Europe High Affinity Nerve Growth Factor Receptor Sales by Type (2015-2020) (K Pcs)
Table 46. Europe High Affinity Nerve Growth Factor Receptor Sales Market Share by Type (2015-2020)
Table 47. Europe High Affinity Nerve Growth Factor Receptor Sales by Application (2015-2020) (K Pcs)
Table 48. Europe High Affinity Nerve Growth Factor Receptor Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific High Affinity Nerve Growth Factor Receptor Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific High Affinity Nerve Growth Factor Receptor Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific High Affinity Nerve Growth Factor Receptor Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific High Affinity Nerve Growth Factor Receptor Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific High Affinity Nerve Growth Factor Receptor Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific High Affinity Nerve Growth Factor Receptor Sales Market Share by Application (2015-2020)
Table 57. Latin America High Affinity Nerve Growth Factor Receptor Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America High Affinity Nerve Growth Factor Receptor Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa High Affinity Nerve Growth Factor Receptor Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America High Affinity Nerve Growth Factor Receptor Revenue Market Share by Country (2015-2020)
Table 61. Latin America High Affinity Nerve Growth Factor Receptor Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America High Affinity Nerve Growth Factor Receptor Sales Market Share by Type (2015-2020)
Table 63. Latin America High Affinity Nerve Growth Factor Receptor Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America High Affinity Nerve Growth Factor Receptor Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa High Affinity Nerve Growth Factor Receptor Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa High Affinity Nerve Growth Factor Receptor Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa High Affinity Nerve Growth Factor Receptor Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa High Affinity Nerve Growth Factor Receptor Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa High Affinity Nerve Growth Factor Receptor Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa High Affinity Nerve Growth Factor Receptor Sales Market Share by Application (2015-2020)
Table 73. Array BioPharma Inc Corporation Information
Table 74. Array BioPharma Inc Description and Major Businesses
Table 75. Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Array BioPharma Inc Product
Table 77. Array BioPharma Inc Recent Development
Table 78. Astellas Pharma Inc Corporation Information
Table 79. Astellas Pharma Inc Description and Major Businesses
Table 80. Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Astellas Pharma Inc Product
Table 82. Astellas Pharma Inc Recent Development
Table 83. AstraZeneca Plc Corporation Information
Table 84. AstraZeneca Plc Description and Major Businesses
Table 85. AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. AstraZeneca Plc Product
Table 87. AstraZeneca Plc Recent Development
Table 88. Daiichi Sankyo Co Ltd Corporation Information
Table 89. Daiichi Sankyo Co Ltd Description and Major Businesses
Table 90. Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Daiichi Sankyo Co Ltd Product
Table 92. Daiichi Sankyo Co Ltd Recent Development
Table 93. Dompe Farmaceutici SpA Corporation Information
Table 94. Dompe Farmaceutici SpA Description and Major Businesses
Table 95. Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Dompe Farmaceutici SpA Product
Table 97. Dompe Farmaceutici SpA Recent Development
Table 98. Genzyme Corp Corporation Information
Table 99. Genzyme Corp Description and Major Businesses
Table 100. Genzyme Corp High Affinity Nerve Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Genzyme Corp Product
Table 102. Genzyme Corp Recent Development
Table 103. Handok Inc Corporation Information
Table 104. Handok Inc Description and Major Businesses
Table 105. Handok Inc High Affinity Nerve Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Handok Inc Product
Table 107. Handok Inc Recent Development
Table 108. Ignyta Inc Corporation Information
Table 109. Ignyta Inc Description and Major Businesses
Table 110. Ignyta Inc High Affinity Nerve Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Ignyta Inc Product
Table 112. Ignyta Inc Recent Development
Table 113. Loxo Oncology Inc Corporation Information
Table 114. Loxo Oncology Inc Description and Major Businesses
Table 115. Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Loxo Oncology Inc Product
Table 117. Loxo Oncology Inc Recent Development
Table 118. Merck & Co Inc Corporation Information
Table 119. Merck & Co Inc Description and Major Businesses
Table 120. Merck & Co Inc High Affinity Nerve Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Merck & Co Inc Product
Table 122. Merck & Co Inc Recent Development
Table 123. Nerviano Medical Sciences Srl Corporation Information
Table 124. Nerviano Medical Sciences Srl Description and Major Businesses
Table 125. Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Nerviano Medical Sciences Srl Product
Table 127. Nerviano Medical Sciences Srl Recent Development
Table 128. Plexxikon Inc Corporation Information
Table 129. Plexxikon Inc Description and Major Businesses
Table 130. Plexxikon Inc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Plexxikon Inc Product
Table 132. Plexxikon Inc Recent Development
Table 133. Proximagen Ltd Corporation Information
Table 134. Proximagen Ltd Description and Major Businesses
Table 135. Proximagen Ltd High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Proximagen Ltd Product
Table 137. Proximagen Ltd Recent Development
Table 138. Rottapharm Biotech Srl Corporation Information
Table 139. Rottapharm Biotech Srl Description and Major Businesses
Table 140. Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 141. Rottapharm Biotech Srl Product
Table 142. Rottapharm Biotech Srl Recent Development
Table 143. Sienna Biopharmaceuticals Inc Corporation Information
Table 144. Sienna Biopharmaceuticals Inc Description and Major Businesses
Table 145. Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 146. Sienna Biopharmaceuticals Inc Product
Table 147. Sienna Biopharmaceuticals Inc Recent Development
Table 148. Tiziana Life Sciences Plc Corporation Information
Table 149. Tiziana Life Sciences Plc Description and Major Businesses
Table 150. Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 151. Tiziana Life Sciences Plc Product
Table 152. Tiziana Life Sciences Plc Recent Development
Table 153. Global High Affinity Nerve Growth Factor Receptor Sales Forecast by Regions (2021-2026) (K Pcs)
Table 154. Global High Affinity Nerve Growth Factor Receptor Sales Market Share Forecast by Regions (2021-2026)
Table 155. Global High Affinity Nerve Growth Factor Receptor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 156. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share Forecast by Regions (2021-2026)
Table 157. North America: High Affinity Nerve Growth Factor Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 158. North America: High Affinity Nerve Growth Factor Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 159. Europe: High Affinity Nerve Growth Factor Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 160. Europe: High Affinity Nerve Growth Factor Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 161. Asia Pacific: High Affinity Nerve Growth Factor Receptor Sales Forecast by Region (2021-2026) (K Pcs)
Table 162. Asia Pacific: High Affinity Nerve Growth Factor Receptor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 163. Latin America: High Affinity Nerve Growth Factor Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 164. Latin America: High Affinity Nerve Growth Factor Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 165. Middle East and Africa: High Affinity Nerve Growth Factor Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 166. Middle East and Africa: High Affinity Nerve Growth Factor Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 167. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 168. Key Challenges
Table 169. Market Risks
Table 170. Main Points Interviewed from Key High Affinity Nerve Growth Factor Receptor Players
Table 171. High Affinity Nerve Growth Factor Receptor Customers List
Table 172. High Affinity Nerve Growth Factor Receptor Distributors List
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. High Affinity Nerve Growth Factor Receptor Product Picture
Figure 2. Global High Affinity Nerve Growth Factor Receptor Sales Market Share by Type in 2020 & 2026
Figure 3. ASP-7962 Product Picture
Figure 4. AZD-7451 Product Picture
Figure 5. BNN-27 Product Picture
Figure 6. Cenegermin Product Picture
Figure 7. CRB-0089 Product Picture
Figure 8. Others Product Picture
Figure 9. Global High Affinity Nerve Growth Factor Receptor Sales Market Share by Application in 2020 & 2026
Figure 10. Bile Duct Cancer
Figure 11. Papillary Thyroid Cancer
Figure 12. Low Back Pain
Figure 13. Lung Cancer
Figure 14. Others
Figure 15. High Affinity Nerve Growth Factor Receptor Report Years Considered
Figure 16. Global High Affinity Nerve Growth Factor Receptor Market Size 2015-2026 (US$ Million)
Figure 17. Global High Affinity Nerve Growth Factor Receptor Sales 2015-2026 (K Pcs)
Figure 18. Global High Affinity Nerve Growth Factor Receptor Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global High Affinity Nerve Growth Factor Receptor Sales Market Share by Region (2015-2020)
Figure 20. Global High Affinity Nerve Growth Factor Receptor Sales Market Share by Region in 2019
Figure 21. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Region (2015-2020)
Figure 22. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Region in 2019
Figure 23. Global High Affinity Nerve Growth Factor Receptor Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by High Affinity Nerve Growth Factor Receptor Revenue in 2019
Figure 25. High Affinity Nerve Growth Factor Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global High Affinity Nerve Growth Factor Receptor Sales Market Share by Type (2015-2020)
Figure 27. Global High Affinity Nerve Growth Factor Receptor Sales Market Share by Type in 2019
Figure 28. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2015-2020)
Figure 29. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type in 2019
Figure 30. Global High Affinity Nerve Growth Factor Receptor Market Share by Price Range (2015-2020)
Figure 31. Global High Affinity Nerve Growth Factor Receptor Sales Market Share by Application (2015-2020)
Figure 32. Global High Affinity Nerve Growth Factor Receptor Sales Market Share by Application in 2019
Figure 33. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2015-2020)
Figure 34. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application in 2019
Figure 35. North America High Affinity Nerve Growth Factor Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 36. North America High Affinity Nerve Growth Factor Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America High Affinity Nerve Growth Factor Receptor Sales Market Share by Country in 2019
Figure 38. North America High Affinity Nerve Growth Factor Receptor Revenue Market Share by Country in 2019
Figure 39. U.S. High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. U.S. High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Canada High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America High Affinity Nerve Growth Factor Receptor Market Share by Type in 2019
Figure 44. North America High Affinity Nerve Growth Factor Receptor Market Share by Application in 2019
Figure 45. Europe High Affinity Nerve Growth Factor Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 46. Europe High Affinity Nerve Growth Factor Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe High Affinity Nerve Growth Factor Receptor Sales Market Share by Country in 2019
Figure 48. Europe High Affinity Nerve Growth Factor Receptor Revenue Market Share by Country in 2019
Figure 49. Germany High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Germany High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. France High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. U.K. High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Italy High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe High Affinity Nerve Growth Factor Receptor Market Share by Type in 2019
Figure 60. Europe High Affinity Nerve Growth Factor Receptor Market Share by Application in 2019
Figure 61. Asia Pacific High Affinity Nerve Growth Factor Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific High Affinity Nerve Growth Factor Receptor Sales Market Share by Region in 2019
Figure 64. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue Market Share by Region in 2019
Figure 65. China High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific High Affinity Nerve Growth Factor Receptor Market Share by Type in 2019
Figure 88. Asia Pacific High Affinity Nerve Growth Factor Receptor Market Share by Application in 2019
Figure 89. Latin America High Affinity Nerve Growth Factor Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America High Affinity Nerve Growth Factor Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America High Affinity Nerve Growth Factor Receptor Sales Market Share by Country in 2019
Figure 92. Latin America High Affinity Nerve Growth Factor Receptor Revenue Market Share by Country in 2019
Figure 93. Mexico High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America High Affinity Nerve Growth Factor Receptor Market Share by Type in 2019
Figure 100. Latin America High Affinity Nerve Growth Factor Receptor Market Share by Application in 2019
Figure 101. Middle East and Africa High Affinity Nerve Growth Factor Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 102. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa High Affinity Nerve Growth Factor Receptor Sales Market Share by Country in 2019
Figure 104. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue Market Share by Country in 2019
Figure 105. Turkey High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Turkey High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Saudi Arabia High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. U.A.E High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa High Affinity Nerve Growth Factor Receptor Market Share by Type in 2019
Figure 112. Middle East and Africa High Affinity Nerve Growth Factor Receptor Market Share by Application in 2019
Figure 113. North America High Affinity Nerve Growth Factor Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America High Affinity Nerve Growth Factor Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe High Affinity Nerve Growth Factor Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe High Affinity Nerve Growth Factor Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific High Affinity Nerve Growth Factor Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America High Affinity Nerve Growth Factor Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America High Affinity Nerve Growth Factor Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa High Affinity Nerve Growth Factor Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed

---